| Amplifluor primers and methods for their use are covered under US patent number 5,866,366 and foreign equivalents and are manufactured under license from Intergen Company LP.
The purchase price of the SNUPE includes a limited, non-transferable license under U.S. Patent Nos. 5,888,819, 6,004,744 and their foreign counterparts owned by Orchid BioSciences, Inc. of Princeton, New Jersey, to perform only the number of Genotypes listed on the packaging for this product (for purposes of this End User License, Genotyping means the detection or quantification of an individual SNP within a single sample) solely for the detection and analysis of SNPs in samples for research and development purposes, either alone or in bona fide collaborations with one or more third parties only and only on an instrument used for gel electrophoretic separation for nucleotide analysis. This license specifically excludes performing services for a third party and any and all diagnostic or therapeutic uses. Information about purchasing licenses to practice primer extensions technology covered by Orchid BioSciences, Inc. patents for any other use may be obtained by contacting the Senior Director for Business Development at Orchid BioSciences, Inc., Princeton, New Jersey, U.S.A., at (609) 750-2200.
Some products relating to SPA, Cytostar-T, LEADseeker, Cy and CyDye may only be available to collaborators and customers within certain of our technology access programmes.
LEADseeker is covered by PCT application number WO 98/07022. CyDye or portion thereof is manufactured under licence from Carnegie Mellon University, US Patent Numbers 5,268,486 and 5,569,587 and Patent Application numbers WO 99/31181 and PCT/GB 99/01746.
The Polymerase Chain Reaction (PCR) is covered by patents owned by Roche Molecular Systems and F Hoffmann-La Roche Ltd. A license to use the PCR process for certain research and development activities accompanies the purchase of certain reagents from licensed suppliers such as GE Healthcare UK Limited and Affiliates when used in conjunction with an authorized thermal cycler.
Taq DNA polymerase and Hot Tub DNA polymerase are sold under licensing arrangements with Roche Molecular Systems, F Hoffmann-La Roche Ltd and the Perkin-Elmer Corporation. Purchase of these products is accompanied by a limited license to use it in the Polymerase Chain Reaction (PCR) process for research in conjunction with a thermal cycler whose use in the automated performance of the PCR process is covered by the up-front license fee, either by payment to Perkin-Elmer or as purchased, ie an authorized thermal cycler.
Notice to purchase: limited licence relating to product codes US79565, 765, 865, 965: This kit is sold pursuant to Authorization from PE Applied Biosystems under one or more of the following US patents: 4,849,513; 5,015,733; 5,118,800; 5,118,802; 5,151,507; 5,171,534; 5,332,666; 5,242,796; 5,306,618; 5,366,860, 4,855,225 and corresponding foreign patents and patent applications. The purchase of this kit includes limited non-transferrable rights (without the right to resell, repackage or further sublicense) under such patent rights to use this kit for DNA sequencing or fragment analysis, solely when used in conjunction with an automated instrument for DNA sequencing or fragment analysis, which has been authorized for such use by PE Applied Biosystems, or for manual sequencing. Purchase of this product does not itself convey to the purchaser a complete license or right to perform automated DNA sequence fragment analysis under the subject patents. No other license is hereby granted for use of this kit in any other automated sequence analysis instrument. The rights granted hereunder are solely for research and other uses that are not unlawful. No other license is granted expressly, impliedly or by estoppel. Further information on licenses to perform DNA sequence and fragment analysis may be obtained by contacting the Director of Licensing at PE Applied Biosystems, 850 Lincoln Center Drive, Foster City, California 94404.
Thermo Sequenase DNA polymerase: notice to purchaser about limited license: The purchase of this kit (reagent) includes a limited non-exclusive sublicense under certain patents* to use the kit (reagent) to perform one or more patented DNA sequencing methods in those patents solely for use with Thermo Sequenase DNA polymerase purchased from GE Healthcare for research activities. No other license is granted expressly, impliedly or by estoppel. For information concerning availability of additional licenses to practice the patented methodologies, contact GE Healthcare Bio-Sciences Corp., 800 Centennial Ave, PO Box 1327, Piscataway, NJ08855, USA. (*US patent numbers: 4,962,020; 5,173,411; 5,409,811 and 5,498,523. Patents pending)
Scintillation proximity assay (SPA) technology is covered by US patent number 4,568,649, European patent number 0,154,734 and Japanese patent application number 84/52452.
7-Deaza-dGTP is sold pursuant to a license and is covered by US Patent number 4804748 issued to Boehringer Mannheim GmbH
Purified farnesyl transferase and its use to perform farneseyl transferase inhibitor screening assay are covered under patents held by The University of Texas System, Austin, Texas (US patent number 5141851) and by ER Squibb & Sons Inc, Princeton, NJ (US patent number 5185248), respectively.
ICE: A method of affinity purification of interleukin converting enzyme is covered by a USA patent owned by Merck & Co Inc (US Patent No. 5278061). The supply of this kit by GE Healthcare does not authorize or license the user to purify ICE by such a method. Methods for conventional chromatography purification of ICE have been published.
Aurodye and Auroprobe are under licence of Janssen Biotech NV, B-2430 Olen, Belgium.
Glycerol tolerant gel buffer - purchase includes a non-exclusive sub-license for use under US Patent number 5,314,595; no other license is granted
Iloprost supplied by agreement with Schering AG, Germany
[3H]LY-278584 is under exclusive license from SmithKline Beecham Pharmaceuticals plc
ECF substrate is manufactured for GE Healthcare by JBL Scientific Inc and is sold under license from JBL Scientific Inc
CDP-Star is protected under one or more of US patents, numbers 5326882 and 4931569 owned by Tropix Inc.
ECL Direct/Alkphos Direct labelling reagents are covered by European patent number 120376B1 and sold under license from European Molecular Biology Laboratory
ECL Direct (RPN3000,3001,3005) is covered by US patent numbers 373017 and 513040 and foreign equivalents and is sold under license from Institut Pasteur
ECL Plus contains Lumigen PS3 substrate and is sold under exclusive license from Lumigen Inc
Fluorescein labelled nucleotides are licensed from Life Technologies Inc under US patent number 4828979 and foreign equivalents for use in laboratory research only
Gene Images hybridization buffer is covered by US patent number 5512436 and foreign equivalents
The purchase of Vistra Green nucleic acid gel stain includes a limited non-exclusive sub-license from Molecular Probes Inc to perform the processes set out in this product literature for research purposes only with instrumentation from GE Healthcare . No other license is granted expressly or implied.
Vistra DNA Labstation 625: purchase of these reagents include a license under one or more of the listed patents and patent applications (namely US patent nos 4,855,255, 4,849,513, 5,015,733, 5,118,802, 5,151,507 and 5,171,534, US patent application no 415,050, 563,010, 570,973, 827,348, 57,565 and 57,566 and corresponding foreign patents and patent applications) to use the reagents contained herein solely for practising one or more of the inventions covered by these patents and patent applications in connection with Vistra DNA Labstation 625 robotic work station for preparing samples for use on DNA Sequencing Machines that have been manufactured by Applied Biosystems Division of The Perkin-Elmer Corporation. No other license is granted to the purchaser either directly or by implication, estoppel or otherwise.
Sequenase T7 DNA polymerase is covered by US patents 4,795,699 and 5,266,466 and others and European patent 264,293B1. T7 Sequenase DNA polymerase - this reagent (kit) is covered by or suitable for use under one or more US patent number: 4,795,699, 4,946,786, 4,942,130, 4,962,020, 4,994,372, 5,145,776, 5,173,411, 5,266,466, 5,409,811 and 5,498,523.
Cy3 dCTP and Cy5 dCTP is manufactured for GE Healthcare by DuPont NEN Life Sciences under US patent numbers 5047519 and 5151507.
CyDye or portions thereof is manufactured under license from Carnegie Mellon University under patent number 5268486 and other patents pending.
Dra II and Dra III are licensed from Boehringer Mannheim GmbH
A license for research use only of the technology which covers the phagemid vector, antibody primers, and amplification method related to the Recombinant Phage Antibody System, and the antibodies or molecules derived therefrom, is granted by Cambridge Antibody Technology, Cambridge Antibody Technology, Science Park, Melbourn, Cambridgeshire SGS 6EJ, UK, Telephone 44(1)763 263233 or Fax 44(1)763 2634131 to the end-user to use the technology, provided the Module has been purchased from GE Healthcare . If you are in doubt as to whether your use of antibodies or molecules derived from them would require a commercial license, please discuss the matter with Cambridge Antibody Technology (see the instruction booklet for the Expression Module).
Use of the Recombinant Phage Antibody System Mouse ScFv Module and Recombinant Phage Antibody System Expression Module is covered by U.S. Patents 5,223,409, 5,403,484 and 5,571,698. Any commercial use of these products, including for the discovery or development of commercial products, requires a license from Dyax Corp.
Ready-To-Go: This product is designed for use in the Random Amplified Polymorphic DNA ("RAPD") process covered by patents and pending applications including US 5,126,239 owned by E.I. duPont de Nemours and Company of Wilmington, DE. GE Healthcare has limited license from E.I. duPont de Nemours and Company to produce and sell this product to the purchaser. The purchase of this product includes a fully paid-up, limited non-exclusive license under the RaPD patent to use this product to perform the RAPD process for research purposes, provided that the RAPD process is conducted using nucleic acid polymerase which has been licensed by Hoffmann-La Roche Inc. for use in the polymerase chain reaction ("PCR") process and provided that RAPD is conducted in conjunction with a thermocycler licensed by the Perkin-Elmer Corporation for use in the PCR process. Purchase of this product conveys to the user the right to utilize the RAPD process for research purposes only. No right or license is conveyed to the purchaser to develop commercial product, to perform any diagnostic testing, or to offer any commercial service using the RAPD process. Further information about acquiring rights under the RAPD process to perform commercial testing or for commercial product development can be obtained by contacting E.I. duPont de Nemours and Company, New Business Development at facsimile number 302-892-1581.
Chromaflow nozzle is covered by U.S. Patents 5,213,683 and 5,282,973 and foreign equivalents.
The AutoLoad Solid Phase Sequencing products are sold under licenses from Sangtec Molecular Diagnostics AB and Pyrosequencing AB. The purchase of these products includes non-transferable rights under EP patent 0 371 437 B1 and US 5,405,746, respectively, and their foreign equivalents, to be used for research purposes only.
Ettan™ CAF™ MALDI Sequencing Kits are protected by patents owned by Procter & Gamble Company and exclusively licensed to GE Healthcare AB and by joint patents issued to both companies. The purchase of Ettan CAF MALDI Sequencing Kits includes a limited license to use the technology for internal research and development, but not for any commercial purposes. No right to perform or offer commercial services or products of any kind using the Sequencing Kits is hereby granted. A license to use the technology for commercial purposes is subject to a separate license agreement with GE Healthcare AB. Please contact the Product Director, Mass Spec. & Sample Handling, GE Healthcare AB, Björkgatan 30, SE-75184, Uppsala, Sweden for details about how to obtain such a license. |
